Nuvilex Inc. (PMCB) vs Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Nuvilex Inc. and Reviva Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Nuvilex Inc. and Reviva Pharmaceuticals Holdings, Inc. are of similar size ($5.0M and $4.9M). Across the 9 metrics below, Nuvilex Inc. leads on 5 and Reviva Pharmaceuticals Holdings, Inc. on 4.

Valuation

Metric PMCB RVPH Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.17 0.42 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 3.67 0.84 0.74
EV/Sales n/m n/m 10.73
Earnings yield (509.84%) (252.17%) (28.84%)
Free cash flow yield (224.12%) (272.92%) (23.03%)

Profitability

Metric PMCB RVPH Biotechnology median
Gross margin 95.64% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.04%) (176.60%) (57.72%)
Return on assets (50.43%) (79.46%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PMCB RVPH Biotechnology median
Revenue growth (TTM) (71.06%) — 5.64%
EPS growth (last fiscal year) (186.83%) 69.56% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMCB RVPH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 40.29 3.56 4.73
Net debt to EBITDA 5.41 0.71 0.96

Dividend

Metric PMCB RVPH Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PMCB RVPH Biotechnology median
Market cap 4.90m 5.00m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack